Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT02261220 |
Title | A Phase 1 Study of MEDI4736 in Combination With Tremelimumab in Subjects With Advanced Solid Tumors |
Recruitment | Completed |
Gender | both |
Phase | Phase I |
Variant Requirements | No |
Sponsors | MedImmune LLC |
Indications | |
Therapies | |
Age Groups: | adult |
Covered Countries | USA | NLD | ISR | GBR | FRA | ESP | DEU | CAN |